Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis

J.T. Phillips, G. Giovannoni, F.D. Lublin, P.W. O'Connor, C.H. Polman, E. Willoughby, W. Aschenbach, A. Pace, R. Hyde, F.E. Munschauer

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)970-979
JournalMultiple Sclerosis
Issue number8
Publication statusPublished - 2011

Cite this